Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

NovaBay Pharmaceuticals (NBY) Other Gross PP&E Adjustments (2016 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $215000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 171.91% to $215000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $215000.0, a 171.91% increase, with the full-year FY2024 number at -$810000.0, up 32.56% from a year prior.
  • Other Gross PP&E Adjustments was $215000.0 for Q3 2025 at NovaBay Pharmaceuticals, down from $275000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $560000.0 in Q3 2021 to a low of -$1.8 million in Q4 2022.
  • A 5-year average of -$545526.3 and a median of -$494000.0 in 2024 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 426.62% in 2021, then plummeted 508.03% in 2022.
  • NovaBay Pharmaceuticals' Other Gross PP&E Adjustments stood at -$461000.0 in 2021, then plummeted by 299.13% to -$1.8 million in 2022, then surged by 34.73% to -$1.2 million in 2023, then surged by 32.56% to -$810000.0 in 2024, then surged by 126.54% to $215000.0 in 2025.
  • Per Business Quant, the three most recent readings for NBY's Other Gross PP&E Adjustments are $215000.0 (Q3 2025), $275000.0 (Q2 2025), and $238000.0 (Q1 2025).